{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:10:35Z","timestamp":1784578235977,"version":"3.55.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072847"],"award-info":[{"award-number":["82072847"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003148"],"award-info":[{"award-number":["82003148"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303585"],"award-info":[{"award-number":["82303585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018684","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","award":["WKZX2023CX100002"],"award-info":[{"award-number":["WKZX2023CX100002"]}],"id":[{"id":"10.13039\/501100018684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06655-4","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T15:57:28Z","timestamp":1750175848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Raman micro-spectroscopy reveals the metabolic alterations in primary prostate tumor tissues of patients with metastases"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoguang","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shupeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9298-9941","authenticated-orcid":false,"given":"Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"issue":"3","key":"6655_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"26","key":"6655_CR2","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMoa1911206","volume":"381","author":"R de Wit","year":"2019","unstructured":"de Wit R, de Bono J, Sternberg CN, Fizazi K, Tombal B, W\u00fclfing C, et al. Cabazitaxel versus abiraterone or enzalutamide in metastatic prostate cancer. N Engl J Med. 2019;381(26):2506\u201318.","journal-title":"N Engl J Med"},{"issue":"10231","key":"6655_CR3","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. proPSMA prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208\u201316.","journal-title":"Lancet"},{"issue":"15","key":"6655_CR4","doi-asserted-by":"publisher","first-page":"12508","DOI":"10.3390\/ijms241512508","volume":"24","author":"IF San Francisco","year":"2023","unstructured":"San Francisco IF, Rojas PA, Bravo JC, D\u00edaz J, Ebel L, Urrutia S, et al. Can we predict prostate cancer metastasis based on biomarkers? Where are we now? Int J Mol Sci. 2023;24(15):12508.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6655_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.eururo.2020.11.021","volume":"79","author":"NK Jairath","year":"2021","unstructured":"Jairath NK, Dal Pra A, Vince R Jr, Dess RT, Jackson WC, Tosoian JJ, et al. A systematic review of the evidence for the decipher genomic classifier in prostate cancer. Eur Urol. 2021;79(3):374\u201383.","journal-title":"Eur Urol"},{"key":"6655_CR6","doi-asserted-by":"publisher","first-page":"217441","DOI":"10.1016\/j.canlet.2025.217441","volume":"2","author":"MT Hindes","year":"2025","unstructured":"Hindes MT, McElligott AM, Best OG, Ward MP, Selemidis S, Miles MA, et al. Metabolic reprogramming, malignant transformation and metastasis: lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Lett. 2025;2:217441.","journal-title":"Cancer Lett"},{"issue":"5","key":"6655_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1476-4598-5-17","volume":"15","author":"LC Costello","year":"2006","unstructured":"Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006;15(5):17.","journal-title":"Mol Cancer"},{"key":"6655_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cca.2019.10.046","volume":"501","author":"H Zheng","year":"2020","unstructured":"Zheng H, Dong B, Ning J, Shao X, Zhao L, Jiang Q, et al. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer. Clin Chim Acta. 2020;501:241\u201351.","journal-title":"Clin Chim Acta"},{"issue":"255","key":"6655_CR9","doi-asserted-by":"publisher","first-page":"116611","DOI":"10.1016\/j.jpba.2024.116611","volume":"15","author":"B Ding","year":"2025","unstructured":"Ding B, Meng W, Zang X, Lv Z. Metabolic characteristics of prostate cancer cells with high metastatic potential revealed by (S)-ethyl 1-(3-(4-chlorophenoxy)-2-hydroxypropyl)-3-(4-methoxyphenyl)-1H-pyrazole-5-carboxylate inhibition. J Pharm Biomed Anal. 2025;15(255):116611.","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"6655_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13046-018-0789-0","volume":"37","author":"J Chen","year":"2018","unstructured":"Chen J, Cao S, Situ B, Zhong J, Hu Y, Li S, et al. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer. J Exp Clin Cancer Res. 2018;37(1):127.","journal-title":"J Exp Clin Cancer Res"},{"issue":"43","key":"6655_CR11","doi-asserted-by":"publisher","first-page":"19651","DOI":"10.1021\/jacs.2c05359","volume":"144","author":"K Dodo","year":"2022","unstructured":"Dodo K, Fujita K, Sodeoka M. Raman spectroscopy for chemical biology research. J Am Chem Soc. 2022;144(43):19651\u201367.","journal-title":"J Am Chem Soc"},{"issue":"12","key":"6655_CR12","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1055-9965.EPI-20-0075","volume":"29","author":"RJ Gillies","year":"2020","unstructured":"Gillies RJ, Schabath MB. Radiomics improves cancer screening and early detection. Cancer Epidemiol Biomarkers Prev. 2020;29(12):2556\u201367.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6655_CR13","doi-asserted-by":"publisher","first-page":"1049016","DOI":"10.3389\/fmolb.2022.1049016","volume":"9","author":"J Zhou","year":"2022","unstructured":"Zhou J, Zhong L. Applications of liquid chromatography-mass spectrometry based metabolomics in predictive and personalized medicine. Front Mol Biosci. 2022;9:1049016.","journal-title":"Front Mol Biosci"},{"issue":"3","key":"6655_CR14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/1541-7786.MCR-20-0548","volume":"19","author":"KL Penney","year":"2021","unstructured":"Penney KL, Tyekucheva S, Rosenthal J, El Fandy H, Carelli R, Borgstein S, et al. Metabolomics of prostate cancer gleason score in tumor tissue and serum. Mol Cancer Res. 2021;19(3):475\u201384.","journal-title":"Mol Cancer Res"},{"issue":"8","key":"6655_CR15","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s10103-022-03610-3","volume":"37","author":"S Kaniyala Melanthota","year":"2022","unstructured":"Kaniyala Melanthota S, Kistenev YV, Borisova E, Ivanov D, Zakharova O, Boyko A, et al. Types of spectroscopy and microscopy techniques for cancer diagnosis: a review. Lasers Med Sci. 2022;37(8):3067\u201384.","journal-title":"Lasers Med Sci"},{"issue":"8","key":"6655_CR16","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1002\/jrs.5389","volume":"49","author":"J de Gala Pablo","year":"2018","unstructured":"de Gala Pablo J, Armistead FJ, Peyman SA, Bonthron D, Lones M, Smith S, et al. Biochemical fingerprint of colorectal cancer cell lines using label-free live single-cell Raman spectroscopy. J Raman Spectrosc. 2018;49(8):1323\u201332.","journal-title":"J Raman Spectrosc"},{"issue":"274","key":"6655_CR17","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1126\/scitranslmed.aaa2384","volume":"7","author":"M Jermyn","year":"2015","unstructured":"Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, et al. Intraoperative brain cancer detection with Raman spectroscopy in humans. Sci Transl Med. 2015;7(274):274\u2013319.","journal-title":"Sci Transl Med"},{"issue":"97","key":"6655_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.bios.2017.05.045","volume":"15","author":"W Liu","year":"2017","unstructured":"Liu W, Wang H, Du J, Jing C. Raman microspectroscopy of nucleus and cytoplasm for human colon cancer diagnosis. Biosens Bioelectron. 2017;15(97):70\u20134.","journal-title":"Biosens Bioelectron"},{"issue":"7","key":"6655_CR19","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1007\/s00432-019-02934-y","volume":"145","author":"Y Li","year":"2019","unstructured":"Li Y, Su S, Zhang Y, Liu S, Jin H, Zeng Q, et al. Accuracy of Raman spectroscopy in discrimination of nasopharyngeal carcinoma from normal samples: a systematic review and meta-analysis. J Cancer Res Clin Oncol. 2019;145(7):1811\u201321.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"6655_CR20","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/brainsci14040301","volume":"14","author":"GG Klamminger","year":"2024","unstructured":"Klamminger GG, Mombaerts L, Kemp F, Jelke F, Klein K, Slimani R, et al. Machine learning-assisted classification of paraffin-embedded brain tumors with Raman spectroscopy. Brain Sci. 2024;14(4):301.","journal-title":"Brain Sci"},{"issue":"1","key":"6655_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41467-022-35696-2","volume":"14","author":"L Huang","year":"2023","unstructured":"Huang L, Sun H, Sun L, Shi K, Chen Y, Ren X, et al. Rapid, label-free histopathological diagnosis of liver cancer based on Raman spectroscopy and deep learning. Nat Commun. 2023;14(1):48.","journal-title":"Nat Commun"},{"issue":"43","key":"6655_CR22","first-page":"e202410919","volume":"63","author":"G Cutshaw","year":"2024","unstructured":"Cutshaw G, Joshi N, Wen X, Quam E, Bogatcheva G, Hassan N, et al. Metabolic response to small molecule therapy in colorectal cancer tracked with Raman spectroscopy and metabolomics. Angew Chem Int Ed Engl. 2024;63(43):e202410919.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"35","key":"6655_CR23","doi-asserted-by":"publisher","first-page":"13172","DOI":"10.1021\/acs.analchem.3c02073","volume":"95","author":"G Cutshaw","year":"2023","unstructured":"Cutshaw G, Hassan N, Uthaman S, Wen X, Singh B, Sarkar A, et al. Monitoring metabolic changes in response to chemotherapies in cancer with Raman spectroscopy and metabolomics. Anal Chem. 2023;95(35):13172\u201384.","journal-title":"Anal Chem"},{"issue":"20","key":"6655_CR24","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1039\/C7AN00969K","volume":"142","author":"E Efeoglu","year":"2017","unstructured":"Efeoglu E, Casey A, Byrne HJ. Determination of spectral markers of cytotoxicity and genotoxicity using in vitro Raman microspectroscopy: cellular responses to polyamidoamine dendrimer exposure. Analyst. 2017;142(20):3848\u201356.","journal-title":"Analyst"},{"issue":"12","key":"6655_CR25","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/sj.bjc.6602638","volume":"92","author":"P Crow","year":"2005","unstructured":"Crow P, Barrass B, Kendall C, Hart-Prieto M, Wright M, Persad R, et al. The use of Raman spectroscopy to differentiate between different prostatic adenocarcinoma cell lines. Br J Cancer. 2005;92(12):2166\u201370.","journal-title":"Br J Cancer"},{"issue":"4","key":"6655_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1464-410X.2010.09185.x","volume":"106","author":"M Tollefson","year":"2010","unstructured":"Tollefson M, Magera J, Sebo T, Cohen J, Drauch A, Maier J, et al. Raman spectral imaging of prostate cancer: can Raman molecular imaging be used to augment standard histopathology? BJU Int. 2010;106(4):484\u20138.","journal-title":"BJU Int"},{"issue":"8","key":"6655_CR27","doi-asserted-by":"publisher","first-page":"87001","DOI":"10.1117\/1.JBO.18.8.087001","volume":"18","author":"L Wang","year":"2013","unstructured":"Wang L, He D, Zeng J, Guan Z, Dang Q, Wang X, et al. Raman spectroscopy, a potential tool in diagnosis and prognosis of castration-resistant prostate cancer. J Biomed Opt. 2013;18(8):87001.","journal-title":"J Biomed Opt"},{"issue":"8","key":"6655_CR28","doi-asserted-by":"publisher","first-page":"e1003281","DOI":"10.1371\/journal.pmed.1003281","volume":"17","author":"AA Grosset","year":"2020","unstructured":"Grosset AA, Dallaire F, Nguyen T, Birlea M, Wong J, Daoust F, et al. Identification of intraductal carcinoma of the prostate on tissue specimens using Raman micro-spectroscopy: a diagnostic accuracy case-control study with multicohort validation. PLoS Med. 2020;17(8):e1003281.","journal-title":"PLoS Med"},{"issue":"7","key":"6655_CR29","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1038\/s41596-021-00559-5","volume":"16","author":"D Traynor","year":"2021","unstructured":"Traynor D, Behl I, O\u2019Dea D, Bonnier F, Nicholson S, O\u2019Connell F, et al. Raman spectral cytopathology for cancer diagnostic applications. Nat Protoc. 2021;16(7):3716\u201335.","journal-title":"Nat Protoc"},{"issue":"6","key":"6655_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1158\/1055-9965.EPI-15-1223","volume":"25","author":"RS Kelly","year":"2016","unstructured":"Kelly RS, Vander Heiden MG, Giovannucci E, Mucci LA. Metabolomic biomarkers of prostate cancer: prediction, diagnosis, progression, prognosis, and recurrence. Cancer Epidemiol Biomarkers Prev. 2016;25(6):887\u2013906.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"6655_CR31","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1158\/1541-7786.MCR-18-1057","volume":"17","author":"EC Randall","year":"2019","unstructured":"Randall EC, Zadra G, Chetta P, Lopez BGC, Syamala S, Basu SS, et al. Molecular characterization of prostate cancer with associated gleason score using mass spectrometry imaging. Mol Cancer Res. 2019;17(5):1155\u201365.","journal-title":"Mol Cancer Res"},{"issue":"10231","key":"6655_CR32","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","volume":"395","author":"MS Hofman","year":"2020","unstructured":"Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208\u201316.","journal-title":"Lancet"},{"issue":"1","key":"6655_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1148\/rg.2018170108","volume":"38","author":"MS Hofman","year":"2018","unstructured":"Hofman MS, Hicks RJ, Maurer T, Eiber M. Prostate-specific membrane antigen PET: clinical utility in prostate cancer, normal patterns, pearls, and pitfalls. Radiographics. 2018;38(1):200\u201317.","journal-title":"Radiographics"},{"issue":"12","key":"6655_CR34","doi-asserted-by":"publisher","first-page":"e53104","DOI":"10.1371\/journal.pone.0053104","volume":"7","author":"M Azrad","year":"2012","unstructured":"Azrad M, Zhang K, Vollmer RT, Madden J, Polascik TJ, Snyder DC, et al. Prostatic alpha-linolenic acid (ALA) is positively associated with aggressive prostate cancer: a relationship which may depend on genetic variation in ALA metabolism. PLoS ONE. 2012;7(12):e53104.","journal-title":"PLoS ONE"},{"issue":"5","key":"6655_CR35","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/pros.21450","volume":"72","author":"CC Chung","year":"2012","unstructured":"Chung CC, Boland J, Yeager M, Jacobs KB, Zhang X, Deng Z, et al. Comprehensive resequence analysis of a 123-kb region of chromosome 11q13 associated with prostate cancer. Prostate. 2012;72(5):476\u201386.","journal-title":"Prostate"},{"issue":"14","key":"6655_CR36","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1093\/hmg\/ddr189","volume":"20","author":"CC Chung","year":"2011","unstructured":"Chung CC, Ciampa J, Yeager M, Jacobs KB, Berndt SI, Hayes RB, et al. Fine mapping of a region of chromosome 11q13 reveals multiple independent loci associated with risk of prostate cancer. Hum Mol Genet. 2011;20(14):2869\u201378.","journal-title":"Hum Mol Genet"},{"issue":"2\u20133","key":"6655_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10555-018-9750-0","volume":"37","author":"AA Panagiotopoulos","year":"2018","unstructured":"Panagiotopoulos AA, Kalyvianaki K, Castanas E, Kampa M. Eicosanoids in prostate cancer. Cancer Metastasis Rev. 2018;37(2\u20133):237\u201343.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"6655_CR38","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1172\/JCI31494","volume":"117","author":"IM Berquin","year":"2007","unstructured":"Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, et al. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest. 2007;117(7):1866\u201375.","journal-title":"J Clin Invest"},{"issue":"2","key":"6655_CR39","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","volume":"188","author":"Y Wang","year":"2024","unstructured":"Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW, et al. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2024;188(2):412\u201329.","journal-title":"Cell"},{"issue":"6487","key":"6655_CR40","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","journal-title":"Science"},{"issue":"1","key":"6655_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","volume":"52","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J. Amino acids in cancer. Exp Mol Med. 2020;52(1):15\u201330.","journal-title":"Exp Mol Med"},{"key":"6655_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1146\/annurev-bioeng-071516-044546","volume":"19","author":"L Yang","year":"2017","unstructured":"Yang L, Venneti S, Nagrath D. Glutaminolysis: a hallmark of cancer metabolism. Annu Rev Biomed Eng. 2017;19:163\u201394.","journal-title":"Annu Rev Biomed Eng"},{"key":"6655_CR43","doi-asserted-by":"publisher","first-page":"1123192","DOI":"10.3389\/fonc.2023.1123192","volume":"13","author":"Z Wang","year":"2023","unstructured":"Wang Z, Wu X, Chen HN, Wang K. Amino acid metabolic reprogramming in tumor metastatic colonization. Front Oncol. 2023;13:1123192.","journal-title":"Front Oncol"},{"issue":"1","key":"6655_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","volume":"26","author":"RJ Kishton","year":"2017","unstructured":"Kishton RJ, Sukumar M, Restifo NP. Metabolic regulation of T cell longevity and function in tumor immunotherapy. Cell Metab. 2017;26(1):94\u2013109.","journal-title":"Cell Metab"},{"issue":"2","key":"6655_CR45","first-page":"192","volume":"25","author":"B Zhao","year":"2023","unstructured":"Zhao B, Wang J, Chen L, Wang H, Liang CZ, Huang J, et al. The role of glutamine metabolism in castration-resistant prostate cancer. Asian J Androl. 2023;25(2):192\u20137.","journal-title":"Asian J Androl"},{"issue":"13","key":"6655_CR46","doi-asserted-by":"publisher","first-page":"e2012748118","DOI":"10.1073\/pnas.2012748118","volume":"118","author":"L Xu","year":"2021","unstructured":"Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, et al. A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer. Proc Natl Acad Sci USA. 2021;118(13):e2012748118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"6655_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-3-319-95693-0_6","volume":"1095","author":"V Odero-Marah","year":"2018","unstructured":"Odero-Marah V, Hawsawi O, Henderson V, Sweeney J. Epithelial-mesenchymal transition (EMT) and prostate cancer. Adv Exp Med Biol. 2018;1095:101\u201310.","journal-title":"Adv Exp Med Biol"},{"issue":"7692","key":"6655_CR48","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature25465","volume":"554","author":"SRV Knott","year":"2018","unstructured":"Knott SRV, Wagenblast E, Khan S, Kim SY, Soto M, Wagner M, et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature. 2018;554(7692):378\u201381.","journal-title":"Nature"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06655-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06655-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:03:11Z","timestamp":1750179791000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06655-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6655"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06655-4","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest to report regarding the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"675"}}